Camille Le Guilcher
Senior scientist discovery research @ Adcytherix
France
Paris
Pharmaceuticals
Physiopathologie, Oncologie, Édition de gènes, Thérapie génique, Virologie, Biomatériaux, Biologie moléculaire, Immuno-oncologie, Recherche en oncologie, Gestion d’équipe, Analyse des données, Travail d’équipe, Expérimentation Animal , Sens de l’organisation, Synthèse, Gestion des communications, Diffusion de la science, Compétences de coordination, Communication externe, Niveau élevé de précision
Experience
Senior scientist discovery research
Adcytherix
Development of antibody drug conjugates to treat high unmet need diseases
Translational Medicine Researcher
Asfalia Biologics
Identification, development and preclinical study management of inductible gene therapy
Contract Teacher
CY Cergy Paris Université
Cergy-Pontoise, Île-de-France, France
Teaching at Master Biomaterials for health: - Biomaterials innovation and industry - Biological organizations and functions
R&D Postdoctoral Researcher at INSERM U 1148
LVTS - Laboratory for Vascular Translational Science
Région de Paris, France
R.H.U Innovations for Liver Tissue Engineering project: Development and preclinical study management of engineered human liver Publications: - Development of 3D hepatic constructs within polysaccharide-based scaffolds with tunable properties (IJMS, 2020) - Interplay between crosslinking and ice nucleation controls the porous structure of freeze-dried hydrogel (Biomater Adv, 2022) - Engineered human liver based on pullulan-dextran hydrogel promotes mice survival after liver failure (Mater Today Bio, 2023) - Fibroblasts mediate endothelium response to angiogenic cues in a newly developed 3D stroma engineered model (Biomater Adv, 2023)
PhD student at INSERM U1174
INSERM
Orsay
Identification and preclinical study of therapeutic targets in liver diseases (liver failure, fibrosis, cirrhosis, NASH) Publication : The P2X4 purinergic receptor regulates hepatic myofibroblast activation during liver fibrogenesis (J Hepatol, 2018) Characterization of a drug candidate that targets T cell activation. Publication : Synthesis and characterization of store-operated calcium entry inhibitors active in the submicromolar range (IJMS, 2020) Patent : Inhibiteurs de l'entrée capacitive du calcium / Inventor member FR3097738, 2021
Research Engineer at INSERM U1174
INSERM
Orsay 91
Internship: Identification and mechanism study of therapeutic targets in chronic liver deseases
Research Assistant at INSERM U757
INSERM
Orsay 91
Internship: Study of inflammation and regeneration processes in acute liver injury
Research Assistant at CNRS-CGM UPR3404
CNRS
Gif sur Yvette 91
Internship: Bibliographic studies of the limitation of drosophila stem cells niches numbers
Student job at R&D départements AMA & THEMIS
EDF
Clamart 92
Help to work safety aspects management and conference organization
Stagiaire
INSERM U757
Orsay 91
Étude du rôle du récepteur P2X7 dans l’inflammation et la lésion au cours d’un modèle d’intoxication hépatique au tétrachlorure de carbone
Education
Pierre and Marie Curie University
Rôle du récepteur purinergique P2X4 dans l'inflammation et la fibrogenèse hépatique
Pierre and Marie Curie University
Université Paris Cité
Université Paris Cité
Paris-Sud University (Paris XI)
Camille Le Guilcher 's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.